Dr Kay Wang
.
Kay is the Oxford Programme Lead of the ARCHIE programme (early Antibiotic use in ‘at Risk’ CHildren with InfluEnza), which is funded by an NIHR Programme Grant for Applied Research. At risk’ children with underlying conditions such as asthma, diabetes, cerebral palsy are more prone than otherwise healthy children to becoming more unwell from influenza-related complications such as chest, ear and throat infections. The ARCHIE programme will develop a robust evidence base for treating these children with antibiotics early during an influenza-like illness. These findings will play a key role in informing antibiotic prescribing policy during influenza epidemics and pandemics.